Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Hair loss after bariatric surgery is common due to nutrient deficiencies and rapid weight loss.

Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.

Targeted testing for telogen effluvium patients can save healthcare costs.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Accurate diagnosis of hair loss types is crucial for effective treatment.

H. pylori infection may be linked to the hair shedding condition Telogen Effluvium.

Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.

Iron supplements may improve hair loss satisfaction even if initial iron levels are normal.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

COVID-19 infection is highly related to increased hair loss, especially in women.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

People with chronic hair shedding have lower antioxidant levels in their blood compared to healthy individuals.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

COVID-19 infection may cause hair loss.

Trichoscopy is easier and quicker than folliscopy for diagnosing telogen effluvium.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.